Press Release|November 29, 2022 Five outstanding research teams share $22.4 million in funding of two new and three renewal Terry Fox New Frontiers Program Project Grants in 2022 competition Five Canadian cancer research teams will share $22.4 million to expand their research into key areas of cancer treatment after winning the 2022 Terry ...
Press Release|November 29, 2022 The Terry Fox Research Institute and the Canadian Institutes of Health Research co-fund new, prestigious grant to tackle high-risk breast cancer A new partnership between the Terry Fox Research Institute (TFRI) and the Canadian Institutes of Health Research (CIHR) will enable a team of multidis...
Press Release|November 29, 2022 L’Institut de recherche Terry Fox et les Instituts de recherche en santé du Canada cofinancent une prestigieuse nouvelle subvention visant à s’attaquer au cancer du sein à haut risque En vertu d’un nouveau partenariat créé entre l’Institut de recherche Terry Fox (IRTF) et les Instituts de recherche en santé du Canada (IRSC), une équ...
Research Highlight|November 26, 2022 TFRI BC Node Research Day: Winning posters We're happy to announce the winning posters of the BC Cancer Summit-TFRI BC Node Research Day.
TFRI News|November 08, 2022 TFRI's 9th Scientific Meeting brings cancer researchers from across Canada to Vancouver Over 230 delegates representing all our TFRI-funded projects were at the event, which featured scientific presentations from principal investigators a...
Press Release|October 19, 2022 The Terry Fox Research Institute Opens New Office in Montreal Based at the Montreal Clinical Research Institute, the new office and team will play an important role as TFRI ramps up its research capacity and cont...
TFRI News|October 19, 2022 Un bureau montréalais pour l'Institut de recherche Terry Fox Le nouveau bureau et la nouvelle équipe de l'Institut de recherche Terry Fox (IRTF), basés à l'Institut de recherches cliniques de Montréal (IRCM), su...
Research Highlight|October 14, 2022 Researchers discover how deadly brain cancer evades treatments While each patient's MRD profile was found to be unique, the team was able to see how these unique features affected the trajectory to their cancer re...
TFRI News|October 05, 2022 Researchers break fundraising record, raise nearly $197k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
TFRI News|August 29, 2022 Support the 2022 Terry Fox Run Challenge The following teams have registered for this year's challenge. You can click on the link next to the team to donate to their run.
TFRI News|July 05, 2022 Launching the 2022 Terry Fox Run Challenge: A letter from Dr. Jim Woodgett The 2022 Terry Fox Run will take place on Sunday, Sept 18th, and it is my pleasure to invite you once again to register for the run and participate in...
Research Highlight|June 03, 2022 New clinical trial in dogs seeks to test innovative “seek and destroy” treatment that could bring new hope to pets and people with cancer A nanoparticle developed by TFRI-funded researchers is being used for the first time as part of an innovative clinical trial in dogs that could pave t...
TFRI News|May 06, 2022 Save the date: Upcoming TFRI events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
News|May 06, 2022 TFRI News: Meet our newest team members A number of new employees have joined the Terry Fox Research Institute over the last few months. Here, we present our newest team members!
Research Highlight|May 06, 2022 Re-defining Li-Fraumeni Syndrome: A catchup with Dr. David Malkin, leader of the Terry Fox New Frontiers Program Project Team studying Li-Fraumeni Syndrome Over the last four years, the team has made significant findings that better help understand, diagnose, and potentially treat this cancer predispositi...
Research Highlight|May 06, 2022 Study identifies gaps in measuring symptom burden in Ontario adolescents and young adults with cancer A study by a Terry Fox New Investigator has revealed gaps in the provincial program designed to measure these symptoms in cancer patients.
Research Highlight|April 06, 2022 New study finds that location of immune cells is critical for immunotherapy response An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a patients’ response to immune therapy.
TFRI News|February 16, 2022 L'Institut de recherche Terry Fox annonce la nomination du Dr André Veillette au poste de directeur exécutif du Réseau des centres d’oncologie du Marathon de l'espoir L'Institut de recherche Terry Fox (IRTF) a le plaisir d'annoncer la nomination d'un éminent médecin et scientifique canadien, le Dr André Veillette, a...
Press Release|February 16, 2022 The Terry Fox Research Institute announces Dr. André Veillette as new Executive Director for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of prominent Canadian physician-scientist, Dr. André Veillette, to the ...
Research Highlight|February 10, 2022 Gut bacteria linked to immune suppression in pancreatic cancer: Study Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...
TFRI News|February 03, 2022 Outstanding early-career researchers will receive $1.8 million after winning 2022 Terry Fox New Investigator Award Four promising, early-career scientists in Montreal, Toronto and Vancouver will each receive $450,000 over the next three years to support groundbreak...
Research Highlight|November 15, 2021 New prognostic biomarkers and cancer-driving genes found in the dark matter of the cancer genome Catalogue of 166 biomarkers generated through machine learning analysis of long non-coding RNAs
Research Highlight|November 01, 2021 TFRI hosts talk on the future of clinical trials featuring Dr. Elizabeth Eisenhauer Last Friday, October 29th, the TFRI hosted a virtual talk with Dr. Elizabeth Eisenhauer, professor emerita, oncology and medicine, Queen's University,...
Research Highlight|November 01, 2021 Lymphoma PPG team presents updates during first event of TFRI's Pan-Can Seminar Series Members of TFRI's BC-based Terry Fox New Frontiers Program Project Grant in Overcoming treatment failure in lymphoid cancers presented during the firs...
Research Highlight|November 01, 2021 EPPIC Researchers present in first Marathon of Hope Cancer Centres Network Seminar Series Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer C...
TFRI News|October 25, 2021 Save the date: Upcoming events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
TFRI News|October 22, 2021 Terry Fox Run Challenge: Researchers break fundraising record, raise nearly $125k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
Research Highlight|October 21, 2021 Study reveals a new target that suggests leukemia in children with Down syndrome could be prevented TFRI-funded researchers in Toronto have uncovered new information on the intricate relationship between the extra copy of chromosome 21 and leukemia, ...
Research Highlight|October 21, 2021 New study shows that exposure to ambient air pollution is a significant contributor to lung cancer among non-smokers Researchers from TFRI’s Pan-Can Lung Study team have pinpointed why more non-smokers are developing lung cancer, providing the basis for creating stra...
Research Highlight|October 21, 2021 TFRI-funded biobank used to make important findings that could help personalize and improve treatments for ovarian cancers Twelve years after it first received TFRI funding, the resource continues to be invaluable for researchers.
Research Highlight|October 21, 2021 New study reveals the genes that drive cancer in a subset of patients with medulloblastoma A new international study led by researchers partly funded by the TFRI has uncovered a number of genes that drive cancer in a subset of patients with ...
Research Highlight|October 21, 2021 Lymphoma team publishes two papers on diffuse large B-cell lymphoma in major journal Both papers help to better understand diffuse large B-cell lymphoma (DLBCL), a heterogeneous form of non-Hodgkin lymphoma that has an average five-yea...
Research Highlight|October 21, 2021 Study identifies that all cancers can be classified into two groups based on presence of YAP protein: Q&A with Dr. Rod Bremner A group of researchers partly funded by the TFRI has found that all cancers can be classified into two distinct groups based on the presence of a prot...
Research Highlight|October 21, 2021 RNA-seq is the best available tool to personalize treatment for patients with acute myeloid leukemia, study finds TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known as whole transcriptome sequencing (RNA-seq) is the best avai...
Research Highlight|September 10, 2021 New study helps understand who will benefit from immunotherapy TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...
TFRI News|August 30, 2021 TFRI launches 2021 Terry Fox Run Challenge The Terry Fox Research Institute (TFRI) is happy to launch its 2021 Terry Fox Run Challenge, an annual event in which our research teams look to claim...
TFRI News|August 19, 2021 The TFRI launches open call for white papers for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce a first call for White Papers for the Marathon of Hope Cancer Centres Network (MOH...
Press Release|August 12, 2021 Les chercheurs de l’Atlantique unissent leurs forces et reçoivent 3,6 millions de dollars de nouveaux fonds provinciaux et nationaux pour accélérer la médecine de précision pour les patients atteints de cancer Pendant deux ans, le groupe collaborera dans un projet pilote commun dans le but de devenir membre à part entière du Réseau des centres d’oncologie du...
Press Release|August 12, 2021 Atlantic researchers join forces, receive $3.6 million in new provincial and national funding to accelerate precision medicine for cancer patients The group will work together under a joint pilot project over two years with the goal of becoming a full partner in the Terry Fox Research Institute’s...
Press Release|July 21, 2021 Distinguished Toronto Scientist Dr. Jim Woodgett Takes Up Leadership of Terry Fox Research Institute on August 1 The Board of Directors of the Terry Fox Research Institute (TFRI) announces the appointment of Jim Woodgett, a senior scientist based at the Lunenfeld...
Research Highlight|June 11, 2021 Oncolytic viruses could provide a precision medicine alternative for some hard-to-treat melanomas A subset of ICI-resistant melanoma patients who display mutations in a specific pathway known as the interferon (IFN)γ-JAK-STAT pathway could benefit ...
Research Highlight|June 08, 2021 Study identifies biomarkers that predict which pancreatic cancer patients with germline BRCA mutations will benefit from personalized therapies using platinums and PARP inhibitors A new study published in Clinical Cancer Research (October 2020) provides insight into which pancreatic cancer patients with germline BRCA mutations w...
Research Highlight|May 27, 2021 Could wearable technology help detect deadly brain cancers early on? Ontario-based researchers led by Terry Fox New Investigator Dr. Phedias Diamandis are researching the possibility of harnessing the power of brain wea...
Research Highlight|May 27, 2021 Study reveals correlation between self-reported symptom burden and hospital visits in patients with Head and Neck Cancers Findings published in the Journal of Clinical Oncology provide the first evidence that tools currently used by patients to report symptoms could be an...
Research Highlight|May 27, 2021 New approach allows researchers to explore areas surrounding tumours to find signatures associated with prostate cancer progression Ontario-based researchers led by Dr. Hansen Housheng He have used single-cell RNA-sequencing to analyze the tumour microenvironment, helping them iden...
Research Highlight|May 27, 2021 Study reveals key genetic mutation that leads to the development of aggressive pediatric brain tumour A study by a Quebec-based team that includes several TFRI-funded researchers has found that many patients with a subtype of gliomas known as G34R/V hi...
Research Highlight|May 26, 2021 New finding sets the stage for clinical trial to better manage cancers that metastasize to the brain TFRI-funded researchers in Montreal have discovered how cancers that metastasize to the brain are able to invade distantly into the surrounding tissue...
TFRI News|May 26, 2021 Le Réseau des centres d’oncologie du Marathon de l’espoir donne un coup d’accélérateur à son plan relatif à la médecine de précision en signant un accord de contribution avec Santé Canada Le gouvernement du Canada et l’Institut de recherche Terry Fox (IRTF) ont signé un accord de contribution qui pave la voie au Réseau des centres d’onc...
Press Release|May 26, 2021 Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Maratho...
TFRI News|March 25, 2021 New Chief Financial Officer for TFRI will help steward new precision medicine projects and longstanding peer-review programs Gordon Schwark will apply his deep understanding of research, academia, funder reporting requirements, and charitable organizations in this new role a...
TFRI News|March 24, 2021 Key leadership hired for new Digital Health and Discovery Platform (DHDP) led by TFRI and main partner Imagia The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of two key leadership personnel to develop, implement and manage the ne...
TFRI News|March 24, 2021 Passionate Terry Foxer with proven track record for executing vision is eager to lead new precision medicine and AI platform Pickard has extensive experience in business planning, operations, contracts, intellectual property, and commercialization, as well as in health data ...
TFRI News|March 24, 2021 Seasoned data expert passionate about using data and digital assets to improve the health care system and provide the best patient care Shari Dworkin is Chief Data Officer for TFRI’s Digital Health and Discovery Network. A strategic leader, data expert and innovator, Dworkin has 20 yea...
TFRI News|March 23, 2021 What Terry Fox and His Legacy Means to Me By Bryce Pickard, Executive Director, Digital Health and Discovery Program Like many worldwide, I grew up hearing the story of Terry Fox, a story syno...
TFRI News|March 10, 2021 Terry Fox Foundation Appoints New Executive Director The Terry Fox Foundation’s Board of Directors is pleased to announce the appointment of Michael Mazza as Executive Director, effective March 1, 2021. ...
Research Highlight|March 01, 2021 Turbocharging the killing power of immune cells against cancer Creating “super soldiers” of specific white blood cells to boost an anti-tumour response has been shown in a series of elegant experiments by TFRI-fun...
Research Highlight|January 08, 2021 Cancer cells hibernate like bears to evade harsh chemotherapy A team led by Dr. Catherine O’Brien, a TFRI-funded scientist at the Princess Margaret Cancer Centre in Toronto, discovered that when under threat, all...
Research Highlight|December 14, 2020 Administering low-dose chemotherapy improves cancer vaccine’s effectiveness in mice models TFRI-funded researchers from the Canadian Oncolytic Virus Consortium (COVCo) have found a way to improve the efficacy of therapeutic cancer vaccines, ...
Press Release|December 14, 2020 Dedicated Terry Foxer and government relations expert Carolyn Chisholm joins TFRI’s Board of Directors The Terry Fox Research Institute is pleased to announce that Carolyn Chisholm, a long-time Terry Fox supporter and an expert in federal and provincial...
Research Highlight|December 14, 2020 Study reveals unique mutational pattern in patients with early-onset pancreatic cancer TFRI-funded researchers have found that patients with early-onset pancreatic cancer have a distinct mutational pattern in a gene called CDKN2A. This d...
Research Highlight|December 14, 2020 New study reveals why some patients with myelodysplastic syndrome become resistant to treatment BC-based researchers led by Drs. Aly Karsan and Sergio Martinez-Høyer have found that mutations in two genes – TP53 and RUNX1 – are responsible for dr...
Research Highlight|December 10, 2020 Two New Frontiers Program Project Grant teams receive $10.9 million for research excellence, expansion to new key areas Two outstanding teams in Ontario will receive $10.9 million over the next six years to advance research into key areas of cancer development after bei...
Research Highlight|December 09, 2020 Lung study team’s findings on early detection translate into first lung cancer screening program in Canada It is a blessing to be able to see the Terry Fox Research Institute translational research program involving eight centres across Canada come to fruit...
Research Highlight|December 08, 2020 Team turns to machine learning to predict patient response to therapy, accelerate precision medicine Dr. Gregory Czarnota and his Terry Fox team are amongst a number of pioneering researchers using machine learning to analyze images of tumours. In doi...
Research Highlight|December 08, 2020 Why does sex affect cancer? New study reveals oncogenomic differences between males and females A new study led by former Terry Fox New Investigator Dr. Paul Boutros reveals key differences in specific genes and in genome-wide phenomena that may ...
Research Highlight|December 08, 2020 Study reveals key genetic mutation that leads to the development of aggressive bone tumour Quebec-based researchers partly funded by the TFRI have discovered that a single mutation in a gene called Histone 3.3 is responsible for the developm...
TFRI News|December 02, 2020 Appointment to Order of Canada recognizes contributions to lymphoid cancer by former TFRI-funded researcher Dr. Joseph Connors A former researcher and oncologist at BC Cancer has been appointed as a Member of the Order of Canada for his outstanding contributions to the field o...
Research Highlight|November 30, 2020 Mapping out the mystery of blood stem cells Using state-of-the art sequencing technology, Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughou...
TFRI News|November 05, 2020 2020 Terry Fox Run Challenge: Researchers show up virtually and raise nearly $98k for cancer research TFRI-funded researchers showed up in full force for the 40th annual Terry Fox Run, raising a whopping $97,934 for cancer research.
Research Highlight|October 22, 2020 Calgary-based researchers discover new tactic that could help stop the growth of a deadly brain cancer The finding, published in Nature Communications, provides a new tactic in the war against cancer that involves reprogramming the immune system to do w...
Research Highlight|September 01, 2020 New study reveals mechanisms that drive chemotherapy resistance in aggressive breast cancers Targeting breast cancer cells that change and adapt to evade chemotherapy in order to survive and grow, could be a new way to treat the often deadly t...
Research Highlight|September 01, 2020 Developing precision medicine alternatives for triple negative breast cancer TFRI-funded scientists in Toronto have made a discovery that could unlock precision medicine treatments for patients diagnosed with triple negative br...
Research Highlight|August 31, 2020 New treatment possibilities for young women diagnosed with rare form of ovarian cancer A recent finding by TFRI-funded researchers in BC may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovaria...
Research Highlight|August 31, 2020 Repurposing cholesterol drugs to treat multiple myeloma A new study TFRI-funded researchers at Princess Margaret Cancer Centre found that drugs prescribed to lower blood cholesterol, known as statins, may b...
TFRI News|August 17, 2020 Marathon of Hope Cancer Centres Network operational plan continues to take shape Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...
Research Highlight|August 17, 2020 Quantifying PTEN loss could help stratify risk of relapse for patients with prostate cancer, study finds A research team in Kingston, Ontario has identified the specific threshold at which PTEN loss becomes clinically significant, presenting a new tool th...
TFRI News|August 17, 2020 Terry Fox Run 2020: Important information for researchers For the first time ever, the 2020 Terry Fox Run will be held virtually. This year’s theme, One Day, Your Way! encourages participants to be creative w...
Press Release|August 12, 2020 Medical oncologist Dr. Tony Reiman joins TFRI Executive as new Atlantic Node Leader The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of Dr. Tony Reiman as its Atlantic Node Leader, representing the provin...
Research Highlight|August 05, 2020 Alberta-based brain researcher team publishes papers in two high-impact journals Members of a translational research project supported by TFRI from 2012 to 2019 continue to make an impact with two recent publications in important m...
Research Highlight|August 05, 2020 Study finds that nanobubbles can exit vascular system, bringing ultrasound-based therapies one step closer to reality Researchers have devised a method to get nanobubbles out of the vascular system intact, presenting a means by which to access and treat deep-seated tu...
Research Highlight|August 05, 2020 Researchers identify mutation associated with improved survival in Diffuse Large B-cell Lymphoma BC-based researchers have found that TMEM30A loss affects the cell membrane, allowing drugs to be delivered into cancer cells more effectively and imp...
Research Highlight|August 05, 2020 New immunotherapy shows promise in treating aggressive adult brain cancer A new CAR-T cell therapy developed by researchers in Hamilton and Toronto may help treat glioblastoma (GBM), an aggressive form of brain cancer that a...
Research Highlight|August 04, 2020 A blood test could predict who benefits from immunotherapy A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immu...
Research Highlight|June 23, 2020 Montreal Cancer Consortium team sheds light on why men may be genetically more prone to melanoma A new study by researchers from the Montreal Cancer Consortium is shedding new light on the role sex genes play in melanoma progression, providing new...
TFRI News|June 19, 2020 TFRI launches 2020 Terry Fox Run Challenge The Terry Fox Research Institute (TFRI) has launched its 2020 Terry Fox Run Challenge, an annual event in which our research teams look to claim top h...
TFRI News|May 28, 2020 TFRI update on COVID-19 and cancer research funding Most cancer research across Canada is curtailed due to the COVID-19 health emergency. Like other philanthropic organizations, our funding for cancer r...
Research Highlight|May 27, 2020 Team isolates rare clones destined to cause relapse within diagnosis samples of acute lymphoblastic leukemia Diagnosis relapse initiating (dRI) clones have unique characteristics that favor relapse and can be found in diagnosis samples from patients, meaning ...
Press Release|May 27, 2020 Clinical trial reveals more effective way to treat aggressive prostate cancers A clinical trial led by BC-based researchers partly funded by the TFRI has revealed that administering abiraterone acetate first, with enzalutamide af...
Research Highlight|May 27, 2020 Promising new antigens found in non-coding ovarian cancer DNA may provide clues for therapeutic vaccine Ovarian cancer researchers in Montreal are hoping newly found molecules might be used to create vaccines for patients with an aggressive form of the d...
Research Highlight|May 27, 2020 New study suggests MRI images can predict how patients with brain metastasis will respond to radiotherapy Quantitative biomarkers derived from conventional MRI in conjunction with machine learning techniques can, potentially, be used to predict outcomes fo...
Research Highlight|May 25, 2020 New study reveals genetic "scars" caused by cancer therapy A new study led by two BC-based researchers affiliated with TFRI and the Marathon of Hope Cancer Centres Network has revealed the genetic "scars" caus...
Research Highlight|May 19, 2020 Researchers identify how hormones and aging affect breast cancer in largest study of its kind After reviewing over 7,000 cancer tissues, researchers partly funded by the TFRI are shedding new light on the relationship between age-related change...
Research Highlight|May 19, 2020 Scientists identify promising immunotherapy combination for pediatric brain cancer An international team that includes TFRI-funded researchers has discovered that combining immunotherapy with a drug called tumor necrosis factor (TNF)...
Research Highlight|April 20, 2020 Pancreatic cancer researchers encouraged by new T-cell finding that identifies patients with hallmarks of an antitumour response A small subset of patients with pancreatic cancer exhibit a T-cell inflamed profile, a finding that could open the door for the potential use of immun...
TFRI News|March 25, 2020 Update on TFRI activities during pandemic We have postponed a number of important meetings such as our 9th Scientific Meeting, and the peer review meetings for our current PPG competition. TFR...
Press Release|February 18, 2020 L’Institut de recherche Terry Fox et les Instituts de recherche en santé du Canada investissent ensemble deux millions de dollars pour soutenir les travaux de nouveaux chercheurs prometteurs Cinq chercheurs de Toronto amorçant une carrière prometteuse dans le domaine du cancer recevront un total de deux millions de dollars pour mener des t...
TFRI News|February 18, 2020 The Terry Fox Research Institute and the Canadian Institutes of Health Research partner to invest $2-million to support research of promising new investigators Five promising, Toronto-based, early career cancer researchers will receive a total of $2-million to undertake research on a deadly brain cancer calle...
TFRI News|January 16, 2020 From the President’s Desk: An update on the Marathon of Hope Cancer Centres Network Dr. Victor Ling provides on update on the Marathon of Hope Cancer Centres Network and discusses what 2020 will bring for the Terry Fox Research Instit...
Research Highlight|January 15, 2020 Lung study team optimistic about new algorithm that can detect lung cancer up to three years before it forms TFRI’s Early Detection Lung Study has developed a way to help doctors predict who is at higher risk of developing the disease.
Research Highlight|January 15, 2020 Targeting the CXCL12/CXCR4 pathway could make curative radio-chemotherapy more effective, less toxic for patients with cervical cancer A groundbreaking discovery by a group of TFRI-funded scientists in Toronto is paving the way for the creation of combination therapies that could make...
Research Highlight|January 15, 2020 Goundbreaking discovery could help block metastasis for two kinds of sarcomas, including the one that claimed Terry Fox TFRI researchers have found that a family of drugs known as Class 1 HDAC inhibitors can block sarcoma metastasis in mice by hindering a cancer cell’s ...
Research Highlight|January 15, 2020 New resource could help researchers use genomic information to determine how a patient will respond to radiation therapy A new computational resource by a group of TFRI-funded researchers in Toronto may one day provide some answers about how patients respond to radiation...
Research Highlight|January 14, 2020 TFRI-funded researchers in Toronto turn 'junk' DNA into gold Mining the rich, uncharted territory of the genome or genetic material of a cancer cell has yielded gold for TFRI-funded scientists at the Princess Ma...
Research Highlight|January 14, 2020 New discovery reveals how Hodgkin lymphoma avoids attack from immune cells A team of lymphoma researchers partly funded by the TFRI has discovered a unique way in which Hodgkin lymphoma cells interact with regular immune cell...
Press Release|January 14, 2020 New member Carol Chiang brings wealth of financial experience to TFRI’s Board of Directors The Terry Fox Research Institute (TFRI) is pleased to announce that Vancouver financial leader Carol Chiang has joined its Board of Directors as a mem...
Research Highlight|January 14, 2020 Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer Toronto-based researchers partly funded by the TFRI have discovered detailed new information about the subtypes of pancreatic cancer.
Research Highlight|January 09, 2020 Virus associated with hand, foot and mouth disease helps fight lung adenocarcinomas in mice TFRI researchers have identified that Coxsackievirus Type B3, a virus commonly associated with hand, foot and mouth disease in children, can significa...
Research Highlight|January 09, 2020 Newly created synthetic cancer cells help advance understanding of leukemias For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...
Research Highlight|January 09, 2020 Study provides new insights on how aggressive breast cancer cells get the energy they need to grow A new study reveals how HER2-positive breast cancer hijack metabolic pathways to produce the extra energy they need to grow and spread.
Research Highlight|January 09, 2020 Team identifies four subtypes for common form of pancreatic cancer based on metabolic pathway alterations A team of Terry Fox-funded researchers has revealed that genetic alterations affecting the metabolic pathways of cancer cells drive outcomes in patien...
Research Highlight|October 16, 2019 TFRI-team creates first-of-its-kind proteogenomic resource for prostate cancer, providing key insights into the biology of tumours The resource combines genomic, epigenomic, transcriptomic and proteomic data from localized, intermediate-risk prostate cancers and sheds light on the...
Research Highlight|October 16, 2019 New finding sheds light on neuroendocrine prostate cancer progression New study reveals how RNA splicing of BHC80 promotes the development of treatment-induced neuroendocrine prostate cancer, providing potential avenue f...
Research Highlight|October 16, 2019 How this TFRI-funded team is finding inspiration in nature and harnessing the power of light to improve cancer care Eight years ago, researchers looking to improve how cancer is diagnosed and treated decided to develop a nanoparticle that mimicked how natural organi...
TFRI News|October 16, 2019 An Update from our President TFRI President and Scientific Director, Dr. Victor Ling, provides an update on how we're progressing in our efforts to make the Marathon of Hope Cance...
TFRI News|October 16, 2019 New TFRI poster and presentation templates for researchers The TFRI poster and presentation templates for researchers reflect our organization's refreshed brand identity.
TFRI News|October 15, 2019 TFRI will host special session on Marathon of Hope Cancer Centres Network at 5th CCRC meeting On Monday, November 4 we will host a special 30-minute presentation on the Marathon of Hope Cancer Centres Network.
Research Highlight|October 04, 2019 Early results from two studies provide insight into who may benefit from immunotherapies Two recent studies partly funded by the TFRI are showing results that provide key insights into how immunotherapy works, and who may benefit from it.
Research Highlight|October 04, 2019 Pan-Canadian team identifies two biomarkers that predict prostate cancer aggressiveness and bone metastasis The discoveries that the proteins p65 and CCN3 indicate cancer aggressiveness could help bridge a major gap that still exists in prostate cancer resea...
Research Highlight|October 04, 2019 Toronto-based team identifies potential target to supress leukemia stem cells Targeting a gene called INKA1 may supress leukemia stem cells (LSCs), stopping the disease in its tracks or preventing relapse in patients who have al...
Research Highlight|October 04, 2019 Collaborators identify new anti-tumour target TP73/p73 with potential to attack cancer stem-like cells and help avoid cancer relapse New discovery provides key insights into the mechanisms used by cancer cells to elude treatment and finds a new target that could be exploited to disr...
Research Highlight|October 04, 2019 Artificial intelligence helps researchers predict if breast cancer patients will respond to chemotherapy before treatment is administered A team of TFRI-funded researchers based out of the Sunnybrook Research Institute in Toronto has devised a new technique that could determine if patien...